FTC and U.S. FDA Warning Letter re: Products Containing CBD October 22, 2019 FDA considers adding a dozen peptides to its bulk drug compounding list RAPS FDA to weigh easing limits on unproven peptides promoted by RFK Jr. The FDA will hold a meeting to consider easing restrictions on more than a half dozen peptide injections, a group of unapproved therapies that have become popular among wellness influencers, fitness gurus Is BPC 157 Legal? Understanding Its Status and Implications The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York